Corrigendum to “Activation of AMP-Activated Protein Kinase and Extracelluar Signal-Regulated Kinase Mediates CB-PIC-Induced Apoptosis in Hypoxic SW620 Colorectal Cancer Cells”

<div>(a) SW620 cells were treated with CB-PIC (40 μg/mL) and/or PD 98059 (ERK inhibitor 5 μM) for 2 h under hypoxia. Western blotting was performed to determine HIF-1α, AMPKα, pAMPKα, pERK, ERK, and β-actin expressions. (b) AMPKα siRNA decreases the activity of hypoxia-induced apoptosis in SW620 cells under hypoxia. Cells were transiently transfected with AMPKα siRNA or control siRNA in the presence or absence of CB-PIC (40 μg/mL) under hypoxia. Western blotting was performed to determine the expressions of HIF-1α, AMPKα, pAMPKα, pERK, ERK, and β-actin.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 5

Figure 5: Corrigendum to “Activation of AMP-Activated Protein Kinase and Extracelluar Signal-Regulated Kinase Mediates CB-PIC-Induced Apoptosis in Hypoxic SW620 Colorectal Cancer Cells” 

Figure 5 | Corrigendum to “Activation of AMP-Activated Protein Kinase and Extracelluar Signal-Regulated Kinase Mediates CB-PIC-Induced Apoptosis in Hypoxic SW620 Colorectal Cancer Cells” 